Vyome Holdings (HIND) Long-Term Deferred Tax (2022 - 2025)
Vyome Holdings (HIND) posted quarterly Long-Term Deferred Tax of $407981.0 for Q4 2025, down 92.43% year-over-year from $5.4 million in Q4 2024, and up 1357.08% quarter-over-quarter from $28000.0 in Q2 2025.
Vyome Holdings (HIND) Long-Term Deferred Tax (2022 - 2025) Analysis & Trends
Vyome Holdings' Long-Term Deferred Tax history runs 4 years deep, the most recent figure standing at $407981.0 for Q4 2025.
- In Q4 2025, Long-Term Deferred Tax fell 92.43% year-over-year to $407981.0; the TTM figure through Dec 2025 stood at $407981.0 (down 92.43% YoY), while the FY2025 annual figure was $407981.0, down 92.43% from the prior year.
- Long-Term Deferred Tax for Q4 2025 stood at $407981.0, up from $28000.0 in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $5.4 million in Q4 2024, with the low at $26000.0 in Q1 2025.
- The 4-year median for Long-Term Deferred Tax is $41500.0 (2023), against an average of $515696.8.
- The sharpest annual moves came in 2024 and 2025: Long-Term Deferred Tax surged 19154.93% in 2024, then slumped 92.43% in 2025.
- Vyome Holdings' Long-Term Deferred Tax stood at $56000.0 in 2022, then slumped by 50.0% to $28000.0 in 2023, then soared by 19154.93% to $5.4 million in 2024, then plunged by 92.43% to $407981.0 in 2025.
- Business Quant data shows HIND's Long-Term Deferred Tax at $407981.0 in Q4 2025, $28000.0 in Q2 2025, and $26000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Vyome Holdings | 16.07 Mn | 8.18 Mn | 11,658.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 407,981.00 |
| Jun 30, 2025 | 28,000.00 |
| Mar 31, 2025 | 26,000.00 |
| Dec 31, 2024 | 5.39 Mn |
| Sep 30, 2024 | 28,000.00 |
| Jun 30, 2024 | 27,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Sep 30, 2023 | 55,000.00 |
| Jun 30, 2023 | 57,000.00 |
| Mar 31, 2023 | 57,000.00 |
| Dec 31, 2022 | 56,000.00 |